Because the number of patients with renal cell carcinoma is low, the disease is considered ‘ rare’, and TORISEL was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 6 April 2006.
TORISEL е определен като „ лекарство сирак “ (лекарство, използвано при редки заболявания).